Advancements in Oncological Dynamic Contrast-Enhanced Mri: A Review and Critical Analysis of Prior Studies
Article Sidebar
Main Article Content
Dynamic contrast-enhanced magnetic-resonance imaging(DCE-MRI) has emerged as a transformative method in oncological imaging, contributing to findings on tumor vascularity, permeability, and treatment response. This review outlines an extensive assessment of DCE-MRI implementation across various malignancies, with a specific emphasis on liver tumors, spinal metastases, and breast cancer. Through examination key pharmacokinetic parameter such as Ktrans, Ve and Kep, the article highlights their diagnostic and prognostic value in discriminating lesion types and forecasting microvascular invasion. It also delves into the integration of artificial intelligence and radiomics in optimizing the interpretability and reproducibility of DCE-MRI data. The review confronts issues related to motion artifacts, regulation, and crossplatform variability, while recommending future directions or clinical uptake and research evolution. Through this synthesis, DCE-MRI is placed as a crucial tool in precision oncology, with the extension of implementation across anatomical systems.
Downloads
References
Shao YY, et al. Lenalidomide as second‐line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy. Alimentary Pharmacology & Therapeutics. 2017 Oct;46(8):722-30.
Chen BB, Shih TT. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World journal of gastroenterology: WJG. 2014 Mar 28;20(12):3125.
Zhang J, et al. Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI. PLoS One. 2020 Jun 10;15(6):e0234520.
O'Connor JP, Jackson A, et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. British journal of cancer. 2007 Jan;96(2):189-95.
Song J, Gu Y, Du T, Liu Q. Analysis of quantitative and semi-quantitative parameters of DCE-MRI in differential diagnosis of benign and malignant cervical tumors. American Journal of Translational Research. 2021 Nov 15;13(11):12228.
Notley SV, Thacker NA, et al. Reliability of Tumour Classification from Multi-Dimensional DCE-MRI Variables using Data Transformations. arXiv preprint arXiv:2303.10014. 2023 Mar 17.
Lee SK, Jee WH, Jung CK, Chung YG. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors. The British journal of radiology. 2020 Nov 1;93(1115):20191035.
Mourad MA, Higazi MM. MRI prognostic factors of tongue cancer: potential predictors of cervical lymph nodes metastases. Radiology and Oncology. 2019 Mar 3;53(1):49
Gao A, et al.,Applying dynamic contrast-enhanced MRI tracer kinetic models to differentiate benign and malignant soft tissue tumors. Cancer Imaging. 2024 May 21;24(1):64.
Shao YY, et al. Lenalidomide as second‐line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy. Alimentary Pharmacology & Therapeutics. 2017 Oct;46(8):722-30.
Yang J, Dong X, et al. Radiomics model of dynamic contrast-enhanced MRI for evaluating vessels encapsulating tumor clusters and microvascular invasion in hepatocellular carcinoma. Academic Radiology. 2025 Jan 1;32(1):146-56.
Wassenaar NP, et al. Optimizing pseudo‐spiral sampling for abdominal DCE MRI using a digital anthropomorphic phantom. Magnetic Resonance in Medicine. 2024 Nov;92(5):2051-64.
Alareer HS, Taher HJ, Abdullah AD. Dynamic contrast enhanced-MRI and apparent diffusion coefficient quantitation for differentiate hepatocellular carcinoma from hepatocellular adenoma. Asian Pacific Journal of Cancer Prevention: APJCP. 2024;25(3):931..
Wang H, Guo S. Solitary hypovascular hepatic nodules: comparison and differentiation between peripheral nodular cholangiocarcinoma and atypical liver hemangioma with MRI. Translational Cancer Research. 2023 Aug 25;12(9):2308.
Chen Y et al., Use of dynamic contrast-enhanced MRI for the early assessment of outcome of CyberKnife stereotactic radiosurgery for patients with spinal metastases. Clinical Radiology. 2021 Nov 1;76(11):864-e1.
Granata V, Grassi R, et al., La Porta M, Brunese MC, De Muzio F, Ottaiano A. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infectious Agents and Cancer. 2021 Jul 19;16(1):53.
Minutoli F et al,. Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging. La radiologia medica. 2020 Mar;125(3):280-7.
Chen BB, Shih TT. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World journal of gastroenterology: WJG. 2014 Mar 28;20(12):3125.
Spratt DE, et al. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases. The Spine Journal. 2016 Mar 1;16(3):291-8.
Kransdorf MJ, Jelinek JS , et al. Soft- Tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 1989; 153: 541–
van Rijswijk CS, Kunz P, et al. Diffusion‐weighted MRI in the characterization of soft‐tissue tumors. Journal of Magnetic Resonance Imaging: An Official Journal of The International Society For Magnetic Resonance In Medicine. 2002 Mar;15(3):302-7.
Wu H, Zhang S, Liang C, Liu H, Liu Y, Mei Y, et al. Intravoxel incoherent motion MRI for the differentiation of benign, intermediate, and malignant solid soft- tissue tumors. J Magn Reson Imaging 2017; 46: 1611–8.
Liu X, et al.,Multi-modality radiomics nomogram based on DCE-MRI and ultrasound images for benign and malignant breast lesion classification. Frontiers in Oncology. 2022 Dec 2;12:992509.
Chung et al., MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. The British journal of radiology. 2012 Oct 1;85(1018):e831-6.
Chu S, et al., Holodny AI. Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy. Spine. 2013 Oct 15;38(22):E1418-24.
Spratt DE, et al. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases. The Spine Journal. 2016 Mar 1;16(3):291-8.
Kumar KA et al. A pilot study evaluating the use of dynamic contrast-enhanced perfusion MRI to predict local recurrence after radiosurgery on spinal metastases. Technology in Cancer Research & Treatment. 2017 Dec;16(6):857-65.
Lis E, et al,.Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy. Neurosurgical focus. 2017 Jan 1;42(1):E9.
Hu P, Chen L, Zhou Z. Machine learning in the differentiation of soft tissue neoplasms: comparison of fat-suppressed T2WI and apparent diffusion coefficient (ADC) features-based models. Journal of Digital Imaging. 2021 Oct;34(5):1146-55.
Vellayappan AP, et al. Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy-a single arm prospective study. Radiology and Oncology. 2022 Dec 13;56(4):525.
Lim HK, Jee WH, et al, incoherent motion diffusion-weighted MR imaging for differentiation of benign and malignant musculoskeletal tumours at 3 T. The British journal of radiology. 2018 Feb 1;91(1082):20170636
Sigmund EE,et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magnetic resonance in medicine. 2011 May;65(5):1437-47
Feng ST, et al.,prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. European radiology. 2019 Sep 1;29(9):4648-59.
Chong HH et al.,Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma≤ 5 cm. European Radiology. 2021 Jul;31(7):4824-38.
Qiao M, Liu C, et al. Breast tumor classification based on MRI-US images by disentangling modality features. IEEE Journal of Biomedical and Health Informatics. 2022 Jan 4;26(7):3059-67.
Lee JH, Yoo GS et al,. Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma. Scientific Reports. 2021 May 17;11(1):10459.
Fotouhi M, et al.,Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning. European Journal of Radiology Open. 2023 Dec 1;11:100535.
Qiao M, Li C, Suo S, et al. Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods. International journal of computer assisted radiology and surgery. 2020 Jun;15(6):921-30
Guo R, Lu G, Qin B, Fei B. Ultrasound imaging technologies for breast cancer detection and management: a review. Ultrasound in medicine & biology. 2018 Jan 1;44(1):37-70.
Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. Journal of the National Comprehensive Cancer Network. 2010 Oct 1;8(10):1157-65.
Jacobs MA, et al.,. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology. 2003 Oct;229(1):225-32.
Segal E, Sirlin CB, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nature biotechnology. 2007 Jun;25(6):675-80.
Zhu Y, et al. Bi-regional dynamic contrast-enhanced MRI for prediction of microvascular invasion in solitary BCLC stage A hepatocellular carcinoma. Insights into Imaging. 2024 Jun 18;15(1):149.
Ronot M, Nahon P et al. Screening of liver cancer with abbreviated MRI. Hepatology. 2023 Aug 1;78(2):670-86..
Zwanenburg A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020 May;295(2):328-38.
Kessler LG, et al., QIBA Terminology Working Group. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Statistical methods in medical research. 2015 Feb;24(1):9-26.
Park JE, Kim D et al. Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement. European radiology. 2020 Jan;30(1):523-36.
Moskowitz CS, et al. Radiomic analysis: study design, statistical analysis, and other bias mitigation strategies. Radiology. 2022 Aug;304(2):265-73.
Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299(17):926–930.
Begg CB, McNeil BJ. Assessment of radiologic tests: control of bias and other design considerations. Radiology 1988;167(2):565–569.
Zhou XH, et al. In: Statistical Methods in Di agnostic Medicine. New York, NY: Wiley-Interscience, 2002; 73–74.
Fornacon-Wood I, Mistry H, Ackermann CJ, et al. Reliability and prog nostic value of radiomic features are highly dependent on choice of fea ture extraction platform. Eur Radiol 2020;30(11):6241–6250.
Pavic M, Bogowicz M, Würms X, et al. Influence of inter-observer de lineation variability on radiomics stability in different tumor sites. Acta Oncol 2018;57(8):1070–1074.
Hawkins DM, et al. (2004). The problem of overfitting. Journal of Chemical Information and Computer Sciences, 44(1), 1–12.
Harrell FE Jr, et al. (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15(4), 361–387
Collins GS, et al. (2015). Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ, 350, g7594.
Gillies RJ, et al. (2016). Radiomics: images are more than pictures, they are data. Radiology, 278(2), 563–577.
Tadimalla S, Wang W, et al. Role of functional MRI in liver SBRT: Current use and future directions. Cancers. 2022 Nov 28;14(23):5860.
Mulyadi R, et al. (2023). Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases: a systematic review. Radiation Oncology Journal, 41(4), 225.
Yoon JH, et al. (2022). Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis. European Radiology, 32(1), 34–45.
Dejene EM, et al. (2023). Unified Bayesian network for uncertainty quantification of physiological parameters in dynamic contrast enhanced (DCE) MRI of the liver. Physics in Medicine & Biology, 68(21), 215018.
Morin O, et al. (2018). A deep look into the future of quantitative imaging in oncology: a statement of working principles and proposal for change. International Journal of Radiation Oncology Biology* Physics*, 102(4), 1074–1082.
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in our journal are licensed under CC-BY 4.0, which permits authors to retain copyright of their work. This license allows for unrestricted use, sharing, and reproduction of the articles, provided that proper credit is given to the original authors and the source.